Showing 34,667 results

Human rights

The consequences of female genital mutilation: a Kenyan perspective

Editor's pick
Key Correspondents
22 September 2015
Adherence

Can’t Swallow a Pill? There’s Help for That

Editor's pick
New York Times
22 September 2015
Pharmaceutical industry

How an obscure drug’s 4,000% price increase might finally spur action on soaring health-care costs

Editor's pick
Washington Post
22 September 2015
New & experimental HIV treatments

HIV Patients Successfully Reach One Year of Virologic Suppression in PRO 140 Monotherapy Study

Editor's pick
Cytodyn press release
22 September 2015
New & experimental HIV treatments

Sangamo BioSciences Reports Updated Clinical Data from ZFP Therapeutic® Program for HIV/AIDS

Editor's pick
Sangamo press release
22 September 2015
Global health initiatives

Report Shows 17 Million Lives Saved

Editor's pick
Global Fund
22 September 2015
Treatment for women

Phase 3 women-only HIV study sheds light on safe and effective antiretroviral treatments

Editor's pick
Science Daily
22 September 2015
Pharmaceutical industry

Nonprofit Gets Back Drug and Reverses 18-Fold Increase in Price

Editor's pick
Bloomberg
22 September 2015
Pharmaceutical industry

Hedge funder Martin Shkreli buys rights to drug used by HIV patients and raises price from $13.50 to $750 per pill

Editor's pick
The Independent
22 September 2015
Global health initiatives

Global Fund will launch its replenishment campaign as a high-level event during the UN General Assembly annual meeting

Editor's pick
Global Fund Observer
22 September 2015
Pharmaceutical industry

Big Price Increase for TB Drug Is Rescinded

Editor's pick
New York Times
22 September 2015
Pharmaceutical industry

GSK takes on Gilead with new two-drug HIV treatments

Editor's pick
Reuters
22 September 2015
Retention & linkage to care

Increasing levels of engagement with care is key to controlling HIV epidemic in US

News
22 September 2015
Confidentiality, consent & medical ethics

AIDS Healthcare Foundation's Demand for Medical Records Endangers Us All

Editor's pick
The Body
21 September 2015
New & experimental hepatitis C treatment

Gilead Announces SVR12 Rates from Four Phase 3 Studies Evaluating a Once-Daily, Fixed-Dose Combination of Sofosbuvir (SOF) and Velpatasvir (VEL) (GS-5816) for the Treatment of All Six Hepatitis C Genotypes

Editor's pick
Gilead press release
21 September 2015
PrEP

Is PrEP 100 % Effective or 100 % Over-Hyped?

Editor's pick
The Body Pro
21 September 2015
New & experimental HIV treatments

Five Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
21 September 2015
The search for a cure

Romidepsin can reverse HIV latency in patients on long-term ART without compromising T-cell function

Editor's pick
Science Daily
21 September 2015
The search for a cure

Cancer drug promises to break down barrier to HIV cure

Editor's pick
The Conversation
21 September 2015
Undetectable viral load & treatment as prevention

Awareness of treatment’s impact on transmission is transforming the lives of couples of mixed HIV status

News
21 September 2015
Sexually transmitted infections epidemiology

'Super-gonorrhoea' outbreak across north of England sparks national alert

Editor's pick
Daily Telegraph
18 September 2015
PrEP

Melbourne poster controversy: Grabbing attention is good, but PrEP is not a magic bullet

Editor's pick
Gay Star News
18 September 2015
PrEP

Activists shout out for PrEP in Melbourne

Editor's pick
Same Same
18 September 2015
Sex workers

Vital new resource on sex work law will help sex workers globally to realise their rights

Editor's pick
Institute of Development Studies press release
18 September 2015